OncoSil Medical Ltd. announced that Chief Financial Officer (CFO) Karl Pechmann has resigned from his position to take on the CFO role at another ASX listed company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | 0.00% | 0.00% | -44.44% |
02:10am | OncoSil Medical Treats Fifth Pancreatic Cancer Patient with Proprietary Device | MT |
03/06 | Oncosil Medical Treats 200th Pancreatic Cancer Patient with Proprietary Device | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.44% | 11.01M | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+18.87% | 249B | |
-1.96% | 216B | |
+11.11% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- OSL Stock
- News OncoSil Medical Limited
- Oncosil Medical Ltd Announces Resignation of Karl Pechmann as Chief Financial Officer